Cargando…
An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models
Broadly neutralizing antibodies are an important treatment for individuals with coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Antibody-based therapeutics are also essential for pandemic preparedness against future Sarbecovirus outbreaks....
Ejemplares similares
-
How RSV Proteins Join Forces to Overcome the Host Innate Immune Response
por: Van Royen, Tessa, et al.
Publicado: (2022) -
GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery
por: van Schie, Loes, et al.
Publicado: (2023) -
Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection
por: Terryn, Sanne, et al.
Publicado: (2016) -
Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profiling
por: Stortelers, Catelijne, et al.
Publicado: (2008) -
Single-Domain Antibodies and Their Formatting to Combat Viral Infections
por: De Vlieger, Dorien, et al.
Publicado: (2018)